STAT-Site WB analyzer
4 Feb 2025
EKF Diagnostics demonstrates its STAT-Site® WB analyzer, showcasing its ability to quantitatively measure β-ketones (Beta-Hydroxybutyrate or β-HB) and glucose in whole blood from capillary or venous samples. Explore how the easy-to-use analyzer utilizes two different test strips to deliver results in just 10 seconds for β-ketones and 5 seconds for glucose. This enables clear and comprehensive management of diabetes patients displaying early symptoms of ketosis, ensuring their rapid treatment and subsequent regular monitoring.
About the company
EKF Diagnostics
Empowering decision-making in point-of-care testing and life sciences applications.
EKF Diagnostics is a leading global diagnostics and biotechnology company specializing in the development, production, and distribution of innovative medical technologies and patient-centric solutions
We are committed to delivering high-quality, reliable, cost-effective tools that enable early detection, accurate diagnosis, therapeutic development, and effective condition monitoring.
Our products are designed to be cost-effective, providing accessible solutions to healthcare providers in diverse clinical settings, including hospitals, clinics, and laboratories.
EKF plays a critical role in the healthcare industry by offering high-quality, value-based diagnostic products. Our point-of-care testing devices allow healthcare professionals to perform rapid tests at the patient’s side, reducing the need for extensive lab testing and delivering quicker results. In addition, EKF is at the forefront of the life sciences sector, providing advanced tools that contribute to biotech development, research, and precision medicine.
Related products
Request Quote for All Products
STAT-Site® WB: Glucose and β-ketone measurement
EKF DiagnosticsThe STAT-Site® WB analyzer from EKF Diagnostics is used to quantitatively determine β-ketones (Beta-Hydroxybutyrate or β-HB) and glucose in whole blood taken from capillary or venous samples.
